Navigation Links
New vaccine for brain cancer

For 18 years, Keith Black, M.D., from Cedars-Sinai Medical Center in Los Angeles has been searching for an effective treatment for brain cancer. While his research moves forward, he’s helping patients live longer along the way.// Latest research involves an effective brain tumor vaccine.

Dr. Black says brain tumors try to hide proteins on the tumor cell surface that the immune system could use to recognize the tumor. By hiding these cells, brain tumors become difficult to eradicate. The first step of research strips these “hidden” proteins from tumor cells and then cultures them from a piece of a patient’s tumor that’s removed with surgery. Next, come dendritic cells. Dendritic cells make up a very small percentage of the white blood cells, but they are the most efficient cells for presenting foreign proteins to the immune system. After isolating the dendritic cells, researchers say, they essentially have developed a technique to put these proteins [that the tumor tries to “hide”] directly on these [dendritic cells] and allow these cells to present these back to the proteins to the immune system by giving these cells back under the skin just as a shot, like a vaccine.

Researchers say the killer immune cells then recognize it and divide into millions of powerful T-cells. Now, when they see the tumor with this protein on the surface, they will try to attack it and kill the tumor cell.

It sounds confusing, but it works. By giving this vaccine, patients are surviving longer. Early research suggests, when combined with chemotherapy, the vaccine increases the two-year survival of patients with grade IV glioblastomas -- the deadliest type of brain cancer -- from 5 percent to nearly 40 percent.

However specialist’s newest endeavor is to inject the vaccine directly into the tumor of patients whose cancer has recurred. In the first patient vaccinated this way, the tumor appears to be at least stabilizing. Ultimately, researchers say they hope that they will be able to eliminate the need for surgery altogether by combining this strategy with non-invasive strategies of destroying the tumor and ... just putting these cells right into the tumor to allow the tumor to be eradicated.

Another research found that age matters when predicting length of survival. Hence Younger patients with a grade IV tumor will do much better than a 70-year-old with a grade II tumor, so there’s something related to age that has a huge impact on the survival of these tumors.

Younger patients have more T-cells ... that can be called up to fight these tumors. That accounts for the entire age effect and the survival of these patients. We know that the immune system is really the reason why younger patients do much better with these aggressive tuors.
'"/>




Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... 23, 2017 , ... The American Academy of Thermology ... development, healthcare training and clinical application of medical infrared imaging, has announced the ... Qualification Courses for Technicians, respectively. , For the first time the AAT is ...
(Date:1/23/2017)... Oregon (PRWEB) , ... January 23, 2017 , ... ... announced today it has earned organic certification under the USDA National Organic Program ... USDA Organic Certification process, we have established organic production and handling systems to ...
(Date:1/23/2017)... Georgia (PRWEB) , ... January 23, 2017 , ... ... in providing high-quality general gynecological care and gynecological services for women ... providing personalized care for a wide variety of reproductive services from routine health ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Life Under Blankets”: an ... an early age. “Life Under Blankets” is the creation of published author, Kimberly Mitchell, ... Campus in Chicago. She went on to pursue a master’s degree in education in ...
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian company dedicated to providing ... big-name retail buyers at the January ECRM Trade Show in Hilton Head, SC. , ... safety standards in all of its creations to help create a more traditional and ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017  Delcath Systems, Inc. (NASDAQ: ... treatment of primary and metastatic liver cancers, today announced ... President and Chief Executive Officer of Delcath will be ... Markets, Thirteenth Annual Investor Conference at the Boca Raton ... , on Tuesday, January 31, 2017 at 10:30 ...
(Date:1/23/2017)... 2017 Varias proteínas clave ... y el riesgo de diálisis están ... pabetalone    Resverlogix Corp. ("Resverlogix" o "la ... un ensayo en fase 1 con sede en Nueva ... severa. Los datos demostraron unos resultados importantes en la ...
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is expected to ... depression worldwide is anticipated to drive the market growth in the coming years. ... antidepressants in the recent years. Continue Reading ... ... ...
Breaking Medicine Technology: